Fraud Settlement at Ranbaxy Set to Spur Exports: Corporate India

Ranbaxy Laboratories Ltd., the Indian drugmaker whose exports to the U.S. were restricted after a fraud investigation, may revive sales to its biggest market after resolving the charges that it sold adulterated medication.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.